Taste receptors in the lungs? Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the receptors could revolutionize the treatment of asthma and other obstructive lung diseases.
In a discovery that could transform asthma treatment, US researchers have found our lungs carry receptors for bitter tastes.
The receptors are the same as those that cluster together as taste-buds on our tongue, Deepak Deshpande from the University of Maryland and colleagues reported in the journal Natural Medicine.
“The detection of functioning taste receptors on smooth muscle of the bronchus in the lungs was so unexpected that we were at first quite skeptical ourselves,” says the study’s senior author, Dr Stephen B. Liggett, Professor of medicine and physiology at the University of Maryland School of Medicine and Director of the Cardiopulmonary Genomics Program.
Dr. Liggett, a Thoracic Physician, says his team found the taste receptors by accident, during an earlier, unrelated study of human lung muscle receptors that regulate airway contraction and relaxation. The airways are the pathways that move air in and out of the lungs, one of several critical steps in the process of delivering oxygen to cells throughout the body. In asthma, the smooth muscle airways contract or tighten, impeding the flow of air, causing wheezing and shortness of breath.
The taste receptors in the lungs are the same as those on the tongue. The tongue’s receptors are clustered in taste buds, which send signals to the brain. The researchers say that in the lung, the taste receptors are not clustered in buds and do not send signals to the brain, yet they respond to substances that have a bitter taste.
For the current study, Dr. Liggett’s team exposed bitter-tasting compounds to human and mouse airways, individual airway smooth muscle cells, and to mice with asthma.
Most plant-based poisons are bitter, so the researchers thought the purpose of the lung’s taste receptors was similar to those in the tongue – to warn against poisons. “I initially thought the bitter-taste receptors in the lungs would prompt a ‘fight or flight’ response to a noxious inhalant, causing chest tightness and coughing so you would leave the toxic environment, but that’s not what we found,” says Dr. Liggett.
There are thousands of compounds that activate the body’s bitter taste receptors but are not toxic in appropriate doses. Many are synthetic agents, developed for different purposes, and others come from natural origins, such as certain vegetables, flowers, berries and trees.
The researchers tested a few standard bitter substances known to activate these receptors. “It turns out that the bitter compounds worked the opposite way from what we thought,” says Dr. Liggett. “They all opened the airway more extensively than any known drug that we have for treatment of asthma or chronic obstructive pulmonary disease (COPD).” Dr. Liggett says this observation could have implications for new therapies. “New drugs to treat asthma, emphysema or chronic bronchitis are needed,” he says. “This could replace or enhance what is now in use, and represents a completely new approach.”
Asthma and COPD together affect 300 million people worldwide. Dr Andrew Scott welcomes this interesting new research finding and reports that the prevalence of asthma in Australia is among the highest in the world: “we estimate that between 10% and 15% of children and between 10% and 12% of adults have asthma. Although it is not a major cause of death, asthma is one of the most common problems managed by doctors and is a frequent reason for the hospitalisation of children”.
The Heart Foundation of Heartweek is on the 6th to 12th May.
The 2012 Influenza Vaccination Program will commence nationally on Thursday 15th March 2012
Children presenting to the emergency department with moderate or severe asthma attacks are less likely to be admitted to hospital if they are treated with systemic corticosteroids within the first 75 minutes after triage, according to a new study.
Central Queensland University conductes the largest Australian sleep census to explore the sleep habits of the nation.
New research shows increased information and education regarding the neurocognitive, cardiovascular and metabolic consequences of untreated OSA, as well as the importance of persisting with the treatment has positive consequences on patients CPAP compliance.
New research results reinforce the value of follow-up tools following right heart catheterisation and provide further support for some of the treatment goals currently suggested by international guidelines.